TradingView
RocketTickers
Sep 13, 2021 4:45 PM

aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Tr Long

NASDAQ:LIFE60
aTyr Pharma, Inc.NASDAQ

Description

⋅
LIFE: aTyr Pharma, Inc.
2021-09-13 07:30:00
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Beyond Technical Analysis
More